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This article presents models to predict mutagenicity, carcinogenicity, developmental toxicity, and skin 
sensitisation for a set of 27 conazoles. The predictions were performed with the program package CAESAR, 
which is available on the Internet. The CAESAR programs were developed to support the European 
Community Regulation on chemicals and their safe use (REACH) and follow the OECD principles for 
(Q)SAR models used for regulatory purposes. The programs provide a number of information, including 
a binary classiﬁ cation of a compound as toxic or non-toxic and information on similar compounds from 
the model’s training sets (similarity sets). In this study we analysed conazole sets using principal component 
analysis (PCA). The predictions were compared to the currently valid classiﬁ cation of these substances in 
the European Union (EU) or to the classiﬁ cation proposed at expert meetings of the Pesticide Risk 
Assessment and Peer Review (PRAPeR) group. The predicted classiﬁ cation for mutagenicity was in good 
agreement with regulatory classiﬁ cation, the predictions for carcinogenicity and developmental toxicity 
showed some discrepancy in particular cases, while the predictions for skin sensitisation showed even 
greater discrepancy.
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Registration of chemicals requires proper risk 
assessment. It consists of four steps: hazard 
identiﬁ cation, hazard assessment, exposure assessment, 
and risk characterisation. Hazard assessment involves 
determination of toxicological properties of a 
compound. They are usually determined experimentally 
applying in vivo or in vitro measurements, which are 
expensive, time-consuming, and sometimes involve 
ethical concerns. Computer-assisted (in silico) 
methods, including Quantitative Structure-Activity/
Property Relationship (QSAR/QSPR) modelling, 
provide alternative methods for the evaluation of 
toxicological endpoints. The use of these methods is 
supported by the European Community Regulation 
on chemicals and their safe use to protect human health 
and environment (REACH - Registration, Evaluation, 
Authorisation and Restriction of Chemical Substances) 
(1). Beside QSAR/QSPR, REACH acknowledges 
other in silico methods for read-across and grouping. 
The REACH Guidance on Information Requirements 
and Chemical Safety Assessment recommends that all 
these methods be used in hierarchical (tiered) order 
(2). Furthermore, the European Chemical Agency (3), 
a body which implements REACH, advises the 
industry to use in silico methods (4). An important 
message is that in their guidelines for (Q)SAR models 
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REACH, US Environmental Protection Agency (US 
EPA) and the Organisation for Economic Co-
operation and Development (OECD) promote 
alternative methods to evaluate chemical hazards, both 
to save animals and to increase information robustness 
(5, 6). QSAR/QSPR modelling rests on the assumption 
that compounds with “similar molecular structures 
show similar properties” (7). QSAR models take 
several steps (8, 9). The ﬁ rst is to determine the data 
set that represents the knowledge base for the model. 
The data set must contain molecular structures and 
their speciﬁ c properties. It is the quality of these data 
that essentially determines the quality of the model. 
Structural data should be selected carefully while the 
property data should be obtained under the same 
laboratory protocols.
The second step is to determine molecular 
structures, where different approaches are possible. A 
molecule can be represented with two-dimensional or 
three-dimensional structures, which is deﬁ ned by the 
positions of all atoms constituting a molecule. In the 
QSAR/QSPR model the structures are represented 
with descriptors. Nowadays, a variety of computer 
software is available to calculate hundreds of 
descriptors at a time. A common method to select the 
most relevant descriptors is the genetic algorithm.
The third step involves selection of the modelling 
method. The most common is multi-dimensional linear 
regression (MLR), which is very fast, and a result is 
given in the form of a multi-linear equation. More 
advanced methods are the principal component 
analysis (PCA), partial least square, Reach regression, 
artiﬁ cial neural networks of different architectures, 
and learning algorithms. In a standard QSAR model 
the property is expressed as a continuous variable, as 
for example dose of activity. Alternatively, the 
property can be given as afﬁ liation to a particular class 
of activity. For classiﬁ cation, a variety of methods is 
available such as linear discriminate analysis, support 
vector machine, or artiﬁ cial neural networks of speciﬁ c 
architectures.
The last step is the testing and the validation of 
models. The questions are: how to test a model and 
how to express the quality of a model. Today, a basic 
concept is accepted that a model should be tested with 
an independent test set. An independent test set means 
a set that was never used in a model-developing 
procedure. Before modelling starts, a test set is 
excluded from the compiled data set. Usually, test sets 
are selected at random from an entire model’s pool of 
data sets. When the model is presented in its ﬁ nal form 
it is tested with this test set. The quality of a model is 
usually expressed as the correlation coefficient 
between predicted and measured values. When a 
model is used for classiﬁ cation its performance is 
usually expressed as a ratio between correctly and 
falsely classiﬁ ed objects. In a binary classiﬁ cation, in 
which response is either positive or negative, model 
responses can be true positive (TP), true negative 
(TN), false positive (FP), or false negative (FN). The 
models are evaluated for their precision (P), speciﬁ city 
(SP), and sensitivity (SE) using the following 
formulas: P=(TP+TN)/(TP+TN+FP+FN); SE=TP/
(TP+FN); and SP=TN/(TN+FP).
To ensure the transparency of the QSAR/QSPR 
models used in regulatory procedures, the OECD 
adopted five principles for their evaluation (10): 
Principle 1: defined endpoint;  Principle 2: 
unambiguous algorithm; Principle 3: definite 
applicability domain; Principle 4: measure of 
goodness-of-fit, robustness and predictivity; and 
Principle 5: mechanistic interpretation, if possible.
CAESAR programs were developed to support the 
use of in silico methods in REACH. They provide 
complex information about the examined structure 
and the models. In addition to prediction of activity, 
these include information about applicability that 
describes how well the examined structure ﬁ ts in the 
training set. Our aim was to analyse these results for 
the entire set of conazoles. The analysis may show 
some common features in the set which may support 
the classiﬁ cation pattern of conazoles. The information 
on applicability should support this classiﬁ cation. 
Some details are described in Methods. The data set 
for conazoles is described in the next section.
Data set
The predictions were performed for a set of 27 
conazoles. Conazoles form a group of chemicals which 
are used in agriculture, in human and veterinary anti-
mycotic therapies, and as non-steroidal anti-oestrogens 
in the treatment of oestrogen-responsive breast 
tumours in postmenopausal women. As active 
substances in plant protection, conazoles marketed in 
the EU must be tested for mutagenicity, carcinogenicity, 
developmental toxicity, and skin sensitisation. 
Conazoles are mostly biologically active substances 
with known mechanisms of activities. For example, 
the anti-mycotic activity of conazole fungicides is 
based on the competitive and reversible inhibition of 
two cytochrome P450 enzymes, sterol 14α-demethylase 
and aromatase. These two enzymes are also present 
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in mammals, and their inhibition can affect mammalian 
steroidogenesis (endocrine disruption) (11). Some 
conazoles like ﬂ usilazole inhibit aromatase with an 
IC50 in the range of cytostatic drugs. Bitertanol, 
triadimenol, tebuconazole, and propiconazole are 
weak inhibitors of aromatase (12). Table 1 presents 
the set of 27 conazoles and their CAESAR classiﬁ cation. 
Some of the substances are fungicides [bitertanol, 
bromuconazole, cyproconazole, difenoconazole, 
diniconazole (-M), epoxiconazole, fenbuconazole, 
ﬂ oquiconazole, ﬂ usilazole, hexaconazole, ipconazole, 
metconazole ,  myclobutani l ,  penconazole , 
propiconazole, prothioconazole, tebuconazole, 
tetraconazole, triadimenol, triticonazole], some are 
herbicides (amitrole, cafenstrole, epronaz, ﬂ upoxam), 
and some are of unknown biological activity. 
Metabolite triazole acetic acid, which is sometimes 
found in plants treated with conazole pesticides, was 
also added to the list. Data on this set have been 
reported in references (11-15).
METHODS
CAESAR models
CAESAR (8, 16) is a project funded by the 
European Commission dedicated to developing in 
silico models for the prediction of ﬁ ve endpoints 
relevant for REACH. These models were developed 
according to the OECD principles for (Q)SAR models 
(10) on high quality data sets following the OECD or 
US EPA standards. To develop the models, different 
programs for the calculation of molecular descriptors 
and descriptor selection were used. These models are 
publicly available over the Internet and with regard 
to the input, only the SMILES code of molecular 
structure is required. For bioconcentration, prediction 
is expressed as a real number and for other four 
endpoints prediction takes the form of a binary 
classification. Beside classification, CAESAR 
provides additional information such a comment, if 
the descriptors are out of range, and about the 
similarity set. The similarity set consists of six 
compounds from the training set, which are the most 
similar to the evaluated one. Similarity is expressed 
with the similarity index. 
Mutagenicity
Details of the CAESAR mutagenicity model are 
given in reference (17). The model is built on a large 
data set of 4204 compounds with their Ames test 
results, which were extracted from the original set 
reported by Kazius et al. (18). For all structures the 
descriptor pool was calculated using MDL software. 
BestFirst algorithm from the Waikato Environment 
for Knowledge Analysis software (WEKA) was 
applied to select the 27 relevant descriptors. Modelling 
combines support to vector algorithm and a rule-based 
system checking for structural alerts. In classiﬁ cation, 
mutagenicity is expressed as “non-mutagen”, 
“mutagen”, or “suspected mutagen”.
Carcinogenicity
Details of the CAESAR carcinogenicity model are 
given in reference (19). The model was built on a set 
of 805 non-congeneric compounds extracted from the 
Carcinogenic Potency Database (CPDBAS). The 
Hybrid Selection Algorithm developed by BioChemics 
Consulting SAS (BCX), France was applied to 
selected eight descriptors from a set of 254 MDL 
descriptors. Furthermore, a cross correlation matrix, 
multi-colinearity, and Fisher ratio were applied to 12 
descriptors taken from a set of 835 DRAGON 
descriptors. For classification we used Counter 
Propagation Artiﬁ cial Neural Networks. A compound 
in the training set was classiﬁ ed as non-carcinogenic 
when mice and rats tested negative, and vice versa, it 
was classiﬁ ed as carcinogenic when at least one test 
was positive. The prediction is expressed as “negative” 
or “positive” together with the class index, which 
indicates how reliable the prediction is.
Developmental toxicity
Details of the CAESAR program for developmental 
toxicity are given in reference (20). The classiﬁ cation 
model is based on the random forest algorithm. It is 
built on the Arena data set, which includes 292 
compounds (21). In the CAESAR program, the 
compounds are binarily classiﬁ ed as developmental 
non-toxicants, if they belong to the FDA categories A 
or B, or as developmental toxicants, if they belong to 
the FDA categories C, D, or X. Descriptors were 
calculated with DRAGON, T.E.S.T., and MDL 
programs. Thirteen molecular descriptors were 
selected using the WEKA software. The testing 
strategy and test results are given in reference (20). In 
the prediction, a compound is predicted as 
“developmental toxicant” or “developmental non-
toxicant”.
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Skin sensitisation
Details of the CAESAR model for skin sensitisation 
are given in reference (22). The data set consists of 
209 compounds selected from the Gerberick data set 
of 211 compounds (23). From a pool of 502 descriptors, 
which were calculated with DRAGON, the hybrid 
selection algorithm singled out seven descriptors. The 
hybrid selection algorithm combines the genetic 
algorithm with regression technique. The model itself 
was based on an adaptive fuzzy partition algorithm 
(24). The prediction is expressed as “active” (for 
sensitisers) or “inactive” (for non-sensitisers), 
accompanied by a class index.
Analysis of data
The predicted classiﬁ cations for the four endpoints 
are presented in Table 1. In the further step we analysed 
the similarity sets, which are given for each prediction. 
For each endpoint we constructed a representation 
space for molecules, which combines all similarity 
sets. In other words, a molecule is represented by a 
multidimensional binary vector, where each vector 
component indicates a compound of the similarity set 
(data available from authors upon request). First, we 
analysed how many times individual compounds of 
the training set appeared in the similarity sets. The 
question was whether a single compound (or several 
compounds) predominated in the predictions for all 
conazoles. In the next step, we considered the binary 
representation vectors as descriptors and implemented 
principal component analysis (PCA) to explore 
similarities between compounds. We wanted to see if 
individual principal axes were predominately 
composed of active or inactive compounds. We also 
wanted to see if the principal axes separated the 
conazoles set in two or more clusters.
The aim of the study was also to predict the 
toxicological class for the five substances in the 
conazole set for which no classiﬁ cation at the EU level 
had been proposed. The predictions for other 
compounds obtained with the CAESAR models were 
compared to the EU classiﬁ cation (15) or to the one 
proposed at Pesticide Risk Assessment and Peer 
Review (PRAPeR) group meetings (14) where no EU 
classiﬁ cation was available.
RESULTS
Mutagenicity
The predictions are shown in Table 1. Testing 
showed that predictions for 22 of 27 compounds were 
true negative, one compound was wrongly predicted 
as suspected positive, and for four compounds no 
experimental data were available. Two compounds, 
climbazole1 and omoconazole2, appeared in ten 
similarity sets and econazole3 in eight. All three 
compounds were veriﬁ ed as (tested) non-mutagenic.
The loadings for the PCA were as follows: the ﬁ rst 
and the second axes combined mofezolac4, climbazole1, 
omoconazole2, and econazole3. The third axis added 
indolebutyric acid5, and haloperidol6. All the 
compounds constituting the ﬁ rst three axes tested 
non-mutagenic.
The score plots for the ﬁ rst and second axis are 
shown in Figure 1a. Four clusters are evident; the ﬁ rst 
consists of 1,2,4-triazole, amitrole, and 1,2,4-triazol 
acetic acid, the second of epronaz and prothioconazole, 
the third of ipconazole, myclobutanil, penconazole, 
cafenstrole, hexaconazole, tetraconazole, metconazole, 
tebuconazole, triadimenol, and cyproconazole, and 
the fourth of bitertanol, ﬂ usilazole, fenbuconazole, 
ﬂ upoxam, epoxiconazole, and difenoconazole. As 
almost all compounds were predicted as non-
mutagenic, the clusters show only the relationship 
regarding the similarity sets. Only cafenstrole and 
epronaz were predicted as mutagenic and epoxiconazole 
as a suspected mutagen. Epronaz, for which no data 
on classification is available, was predicted as 
mutagenic. This prediction was supported by similarity 
with six compounds in the same set, which all tested 
mutagenic. On the other hand, the predictions for 
cafenstrole and epoxiconazole were not supported by 
similarity sets. The similarity set for cafenstrole was 
composed of six compounds tested non-mutagenic 
and for epoxiconazole of four compounds tested non-
mutagenic and two mutagenic. The false positive 
prediction for epoxiconazole was probably due to the 
presence of epoxide and aziridine groups in the 
molecule, which were recognised as mutagenic by the 
program. Diniconazole-M was predicted as non-
mutagenic with an equal number of compounds tested 
mutagenic and non-mutagenic in the similarity set, 
just like the set for diniconazole. Ipconazole was 
predicted as non-mutagenic, as all six compounds in 
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Table 1 CAESAR predictions and comparison with EC regulation for the set of 27 conazoles. 
No Substance CAS






















2 amitrole2 61-82-5 N N P N P P P N
3 bitertanol3 55179-31-2 N N N N N P P N
4 bromuconazole4 116255-48-2 N N P N P P P N
5 cafenstrole5 125306-83-4 P no data P no data P no data P no data
6 cyproconazole6 94361-06-5 N N N N P P P N
7 difenoconazole7 119446-68-3 N N P N N N P N
8 diniconazole8 76714-88-0 N N N N P N P N




SP N P P N P P N
11 epronaz11 59026-08-3 P no data P no data P no data P no data
12 fenbuconazole12 114369-43-6 N N N N P N P N
13 ﬂ uquinconazole13 136426-54-5 N N P N P N P N
14 ﬂ upoxam14 119126-15-7 N N N N P N N N
15 ﬂ usilazole15 85509-19-9 N N P P N P P N
16 hexaconazole16 79983-71-4 N N P N P N P P
17 ipconazole17 125225-28-7 N no data P no data P no data P no data
18 metconazole18 125116-23-6 N N P N P P P N
19 myclobutanil19 88671-89-0 N N N N P P P N
20 penconazole20 66246-88-6 N N N N P P P N
21 propiconazole21 60207-90-1 N N P N P N P P
22 prothioconazole22 178928-70-6 N N N N P P P P
23 tebuconazole23 107534-96-3 N N N N P P P N
24 tetraconazole24 112281-77-3 N N P N P N N N




28711-29-7 N N N no data P no data P no data
27 triticonazole26 131983-72-7 N N P N P N P N
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precision (P) of the model for the analysed set of 
conazoles was 95.6 %, speciﬁ city (SP) 95.6 %, while 
sensitivity (SE) could not be calculated because the 
set did not contain mutagenic compounds.
Carcinogenicity
Table 1 shows that of the 27 conazoles, 15 were 
predicted as positive (carcinogenic) and 12 as negative 
(non-carcinogenic). The loadings show the following: 
the ﬁ rst axis is a combination of pirinixic acid (tested 
positive), ﬂ uconazole (tested positive), and neﬁ racetam7 
(tested negative). The second axis is a combination of 
bemitradine (tested positive) loxtidine8 (tested 
positive), and pyrazapon9 (tested negative), and the 
third axis is a combination of entramin10 (tested 
p o s i t i v e ) ,  f o r m i c  a c i d  2 - ( 4 - m e t h y l - 2 -
thiazolyl)hydrazide11 (tested positive), and ionidamine12 
(tested negative).
The score plot shows ﬁ ve clusters (Figure 1b). 
Three clusters are dominated by compounds predicted 
as positive and two clusters by compounds predicted 
as negative. The clusters of compounds predominately 
predicted as positive are: 1,2,4-triazole (false positive), 
amitrole (false positive) and 1,2,4-triazol acetic acid 
(predicted as negative with no available data), cluster 
of ﬂ uquinconazole (false positive), ﬂ upoxam (true 
negative) and ﬂ usilazole (false positive) and cluster 
of ipconazole (positive with no data), propiconazole 
(false positive), cyproconazole (true negative), 
metconazole (false positive), triticonazole (false 
positive). The first cluster of (mostly) negative 
compounds consists of hexaconazole (false positive), 
myclobutanil (true negative), penconazole (true 
negative), tebuconazole (true negative), and the second 
one of cafenstrole (predicted as positive with no 
available data), diniconazole-M (predicted as negative 
with no available data), diniconazole (true negative), 
tetraconazole (false positive), and triadimenol (true 
negative). The model correctly predicted epoxiconazole 
and ﬂ usilazole which are classiﬁ ed as carcinogenic in 
the Regulation (EC) No. 1272/2008 (15). Three out 
of five substances, which are not listed in the 
Regulation (EC) No. 1272/2008 (15) or were not 
evaluated by PRAPeR group (14) (see Table 1), were 








ipconazole) and two as non-carcinogenic (diniconazole-
M, 1,2,4-triazol acetic acid). Looking at the similarity 
sets for still unclassiﬁ ed compounds, we can see that 
a set for cafenstrole, diniconazole-M, and epronaz 
consists of three compounds tested and predicted as 
carcinogenic and three as non-carcinogenic. For 
ipconazole the set consists of two tested and predicted 
carcinogenic compounds, one correctly predicted non 
carcinogenic compound, and three carcinogenic 
substances predicted as non-carcinogenic. The 
similarity set for 1,2,4-triazol acetic acid is composed 
of three predicted and tested positive compounds and 
three compounds predicted negative, but  positive. 
The calculated precision (P) of the model was 54.5 %, 
speciﬁ city (SP) 50 %, and sensitivity (SE) 100 %. Low 
speciﬁ city indicates high number of false positive 
predictions. On the other hand, sensitivity is very high. 
This is because only two compounds from the data set 
(Table 1) were predicted and conﬁ rmed as positive 
(true positive) and no compound was predicted 
negative and tested positive (false negatives).
Developmental toxicity
Five conazoles were predicted as developmental 
non-toxicants and 22 as developmental toxicants. 
1,2,4-triazole, a known developmental toxicant, was 
predicted as non-toxicant with the remark to be “out 
of descriptors” range. This remark means that the 
numerical values of one of more descriptors are out 
of the interval, which is defined by compounds 
included in the training set. Such a prediction should 
be evaluated with caution.
Looking at the similarity sets of conazoles in the 
ﬁ rst cluster, we identiﬁ ed three compounds that appear 
in all sets: acetazolamide (tested toxicant), allantoin13 
(tested non-toxicant), and nitrofurazone14 (tested non-
toxicant).
Loadings are the following: the largest part of the 
first axis includes tolmetin (tested toxicant), 
chlorpheniramine (tested non-toxicant), and 
acemetacin15 (tested non-toxicant); the second axis 
includes haloperidol16 (tested toxicant), triprolidine 
(tested toxicant), and Spectrum_00017117 (tested 
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(tested toxicant), allantoin (tested non-toxicant), 
acemetacin (tested non-toxicant), and nitrofurazone 
(tested non-toxicant).
In the score plot (Figure 1c) five clusters are 
evident: the first consists of 1,2,4-triazole (false 
negative), amitrole (true positive), and 1,2,4-triazol 
acetic acid (predicted positive with no available data), 
the second cluster consists of bitertanol (false 
negat ive) ,  d i fenconazole  ( t rue  negat ive) , 
ﬂ uquinconazole (false positive), and ﬂ upoxam (false 
positive), the third cluster of epoxiconazole (false 
negative) and fenbuconazole (false positive), the 
fourth of hexaconazole (false positive) and 
myclobutanil (true positive), and the ﬁ fth cluster of 
cafenstrole (predicted as positive with available no 
data), tetraconazole (false positive), and triadimenol 
(true positive). Amitrole was correctly predicted as a 
developmental toxicant (true positive). Its similarity 
set was composed of four correctly predicted 
developmental non-toxicants and two developmental 
toxicants. On the other hand, 1,2,4-triazole was 
wrongly predicted as a developmental non-toxicant 
(false negative). Cafenstrole, which is in the score plot 
situated close to both compounds, is predicted as 
toxicant. Due to different predictions for both 
neighbours no ﬁ nal conclusion on its toxicity can be 
made. 
Triadimenol and tetraconazole were predicted as 
developmental toxicants. The predictions were 
supported by similarity sets, which contain compounds 
predicted and tested as developmental toxicants.
Ipconazole, diniconazole-M, and epronaz, for 
which no data are available, were predicted as 
toxicants. The similarity set for ipconazole is 
composed of three developmental toxicants and three 
developmental non-toxicants. Most of these compounds 
were also found in the similarity set of metconazole, 
which was correctly predicted as toxicant (true 
positive). The similarity sets for diniconazole and 
diniconazole-M, which include ﬁ ve correctly predicted 
developmental toxicants and two correctly predicted 
developmental non-toxicants are identical. This is not 
a surprise taking into consideration that diniconazole-
M is the R isomer of diniconazole. Epronaz was 
predicted as developmental toxicant with the similarity 
set composed of four correctly predicted toxicants and 
two correctly predicted non-toxicants. However, 
because of dissimilarity between epronaz and the rest 
of the training set, it is difficult to predict its 
developmental toxicity.
Figure 1  Figures show score plots for mutagenicity (a), 
carcinogenicity (b), developmental toxicity (c), and 
skin sensitisation (d). The x and y axes represent the 
ﬁ rst and the second principal axes, respectively. In 
all plots, bold indicates toxic, regular non-toxic, and 
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The calculated precision (P) of the model for a set 
of conazoles was 45.5 %, speciﬁ city (SP) 11.1 %, and 
sensitivity (SE) 69.2 %.
Skin sensitisation
All compounds with the exception of ﬂ upoxam 
and tetraconazole were predicted as active, which 
means that only these two compounds were not 
expected to sensitise skin.
The predictions and the analysis of similarity sets 
show that most conazoles are on the active side of 
representation space. Only five conazoles were 
correctly predicted, three of them active and two 
inactive. Even the right prediction for ﬂ upoxam and 
tetraconazole as inactive was not supported by the 
similarity sets, where most compounds were predicted 
and conﬁ rmed as active. The correct prediction for 
prothioconazole (active) should be considered with a 
caution, because the proposed classiﬁ cation as a skin 
sensitiser (14) was based on the presence of an 
impurity in the technical material and not because of 
the properties of the substance itself. Table 1 shows 
that in most cases the predictions are in conﬂ ict with 
the classiﬁ cation in the EU Regulation (14), where 
most of the compounds are classiﬁ ed as inactive. Five 
conazoles for which no classiﬁ cation is available, were 
predicted as active. The prediction was supported by 
the similarity set of six compounds, where active 
(sensitising) compounds prevailed. Due to the general 
discrepancy between predictions and measured data, 
these predictions are less reliable (16). The calculated 
precision (P) of the model for the set of conazoles was 
22.7 %, speciﬁ city (SP) 10.5 %, and sensitivity (SE) 
100 %.
CONCLUSIONS
This article reports classiﬁ cation of 27 conazoles 
on four different endpoints. The similarity analysis 
was performed on four different representation spaces, 
which were constructed from similarity sets obtained 
from CAESAR programs. The representation spaces 
are parts of training sets, i.e., the sets used for 
developing models and are different for four endpoints. 
When using the QSAR/QSPR models, the analysis of 
applicability domain is crucial. An example is the 
prediction of developmental toxicity for 1,2,4-triazole, 
which is a known developmental toxicant. The 
CAESAR prediction is non-toxic with the remark “out 
of descriptor range”. The model for the four endpoints 
shows clearly different properties. In some cases the 
predicted and regulatory classification are in 
accordance, in other cases not. The reason for 
discrepancies may be that the models were built on 
limited data sets using structural descriptors. On the 
other hand, regulatory classiﬁ cation is an extensive 
procedure, which includes different steps and takes 
into consideration different facts. Our aim is to 
promote in silico models to become a part of this 
procedure. For now, they can be used as a valuable 
method for setting priorities among chemicals for 
further testing, but not as standalone methods for 
classiﬁ cation.
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Izvleček
NAPOVEDI MUTAGENOSTI, KARCENOGENOSTI, RAZVOJNE TOKSIČNOSTI IN KOŽNE 
OBČUTLJIVOSTI ZA NIZ KONAZOLOV
V članku predstavimo modele za napoved mutagenosti, karcenogenosti, razvojne toksičnosti in kožne 
občutljivosti za niz 27 konazolov. Uporabili smo programski paket CAESAR, ki je dostopen preko interneta. 
Programi so bili razviti v podporo Evropske Regulacije za varno uporabo kemikaljij REACH in ob 
upoštevanju OECD principov za validacijo (Q)SAR modelov, ki se uporabljajo za regulatorne namene. 
Pri napovedi dobimo različne informacije; binarno klasiﬁ kacijo kot toksičen ali ne-toksičen in informacijo 
o šestih najbolj podobnih spojinah iz testnega niza (podobnostni niz). Ti nizi so bili analizirani z metodo 
glavnih osi (PCA). Napovedi smo primerjali z trenutno veljavnimi klasiﬁ kacijami spojin, ki so bile na 
Evropski komisiji že sprejete, ali pa so predlagane na srečanjih ekspertov (Pesticide Risk Assessment and 
Peer Review (PRAPeR) group). Napovedane klasiﬁ kacije se dobro ujemajo z sprejeto klasiﬁ kacijo za 
mutagenost. Za karcenogenost in razvojno toksičnost se napovedi v nekaterih primerih ujemajo, v nekaterih 
ne. Pri kožni občutljivosti smo našli več diskrepanc. Za pet spojin, za katere ni eksperimentalnih podatkov 
smo diskutirali napovedi.
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